U.S. pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India

The medicine has been issued an Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA) to treat hospitalised COVID-19 patients.